Nadezhda Smurova

Ms. Nadezhda Smurova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2023 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
APA. S. Pendyukhova
A. S. Pendyukhova
NBNatalia Belkova
Natalia Belkova
JSJ. S. Savinova
J. S. Savinova
NVN. M. Voropaeva
N. M. Voropaeva
NSNadezhda Smurova
Nadezhda Smurova
LRL. V. Rychkova
L. V. Rychkova
Background. Using probiotic preparations based on consortia of microorganisms not only helps to restore the balance of the intestinal microbiota, but also increases the therapeutic effect of probiotics. Promising sources for obtaining probiotic consortia are milk products that have undergone natural fermentation with the help of spontaneously formed microbial consortia. The aim. To study the structure of five microbial consortia with probiotic properties from naturally fermented milk products and to assess in vitro their antagonistic activity against opportunistic bacteria and a representative of the human normobiota – Escherichia coli. Materials and methods. The structure of bacterial consortia was analyzed by sequencing methods. The antagonistic activity of the consortia was assessed by the disk diffusion method. Results. It has been established that the studied microbial consortiums are represented by Enterococcus spp. and Streptococcus spp. bacteria. In consortiums No. 1, No. 2, and No. 3, Enterococcus bacteria dominated, while in consortiums No. 4 and No. 5, Streptococcus dominated. Antagonistic activity was shown against four isolates of opportunistic bacteria: Klebsiella pneumoniae No. 493, Enterobacter hormaechei No. 372, Staphylococcus aureus No. 4 and Pseudomonas aeruginosa No. 25 IMB, as well as against one representative of the human normobiota – Escherichia coli No. 495. The highest growth delay zone is found in E. coli No. 495 isolate. Three test cultures (K. pneumoniae No. 509, E. coli ATCC25922 and P. aeruginosa No. 3 IMB) exhibited more dense growth around probiotic consortia. Conclusion. The results of the study showed that the effect of probiotic consortia differing in the composition of microorganisms can be neutral and bactericidal. The presence of antagonistic activity in the studied microbial consortia against multiresistant isolates of opportunistic bacteria is a prospect for creating probiotics with antibacterial properties.

14 March 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
NBNatalia Belkova
Natalia Belkova
UNUliana Nemchenko
Uliana Nemchenko
EKElizaveta Klimenko
Elizaveta Klimenko
NSNadezhda Smurova
Nadezhda Smurova
RZRaisa Zugeeva
Raisa Zugeeva
ESEVGENII SAVILOV
EVGENII SAVILOV
Pseudomonas aeruginosa is one of the leading causes of nosocomial respiratory tract infections, significantly affecting morbidity and mortality. It can persist in the lungs of patients with cystic fibrosis (CF) for extended periods because of its adaptive capacity. The main aim of this study was to determine the phenotypic and genotypic resistance to antibiotics of clinical isolates of P. aeruginosa that persist in patients with CF receiving long-term antimicrobial therapy. The study included nine strains of P. aeruginosa isolated from the sputum of patients with CF admitted to the hospital. Susceptibility to antibiotics was determined using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Whole-genome sequencing was performed for phylogeny, sequence typing, and to identify antibiotic-resistant genes. The study showed that during long-term persistence in the lungs of patients receiving antibacterial therapy, the restoration of susceptibility to antibiotics occurred in some cases. Multilocus sequence typing and phylogeny revealed six sequence types. Functional annotation identified 72 genes responsible for resistance to antibacterial and chemical substances, with either chromosomal or plasmid localisation.

25 March 2024 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
NBNatalia Belkova
Natalia Belkova
EKElizaveta Klimenko
Elizaveta Klimenko
UNUliana Nemchenko
Uliana Nemchenko
EGEkaterina Grigorova
Ekaterina Grigorova
KSK. O. Sitnikova
K. O. Sitnikova
ESEVGENII SAVILOV
EVGENII SAVILOV
Klebsiella pneumoniae (Kp) species complex is a genetically and ecologically diverse group of bacteria that causes a wide range of infections in humans and animals.The aim. To carry out biological characterization and genotyping based on the study of different loci of Klebsiella pneumoniae clinical isolates.Materials and  methods. The object of the study was three Klebsiella pneumoniae clinical isolates from different biotopes of patients from a regional children’s multidisciplinary hospital. We used a complex of bacteriological, molecular genetic and bioinformatic methods. Genotyping of the isolates was carried out using the Pasteur Institute service for strains of the K. pneumoniae species complex.Results. All strains were sensitive to antimicrobial drugs from carbapenem (imipenem, meropenem) and tetracycline groups (tigecycline), and demonstrated high sensitivity to the Klebsiella polyvalent bacteriophage. The antibiotic resistance of the Kp ODKB-16 and ODKB-81 isolates to seven and eight antimicrobial drugs, respectively, was registeredBased on the results of multi-locus sequence typing, all strains were assigned to Kp1 phylogroup, K2 type and differed in sequence type, scgMLST629 profile and KL type. Kp ODKB-16 strain was identified as ST-65, scgST-11107, KL2; ODKB-07 strain – as ST-219, scgST-6401, KL125KL114; ODKB-81 strain – as ST-86, scgST-2800, KL2KL30. The virulence gene clusters AbST, CbST, YbST, SmST, and RmST have been characterized only in the genome of the Kp ODKB-16 isolate, allowing it to be characterized as highly virulent with multidrug resistance (MDR). Additionally, genes responsible for the synthesis of types 1 and 3 fimbrial adhesins were registered in all strains, and ter operon loci were identified only in Kp ODKB-16. Resistome analysis showed that all strains had 2b genotype. Plasmids were found in the genomes of Kp ODKB-81 (IncI2) and ODKB-16 (IncFIA + IncFIB + IncHI1B).Conclusion. We used a comprehensive framework for genomic taxonomy of clinical isolates, which can contribute to the unification of global and regional peculiarities of the developing and microevolution of bacterial pathogens.

1 March 2026 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
NSNadezhda Smurova
Nadezhda Smurova
AGA. S. Gorkavenko
A. S. Gorkavenko
RZR. E. Zugeeva
R. E. Zugeeva
NBN. L. Belkova
N. L. Belkova
NCN. N. Chemezova
N. N. Chemezova
LRL. V. Rychkova
L. V. Rychkova

30 May 2026 in Frontiers in Bioscience-Elite
Verified
Journal Article
Open access
PDF file
EKElizaveta Klimenko
Elizaveta Klimenko
NBNatalia Belkova
Natalia Belkova
AGAnna Gorkavenko
Anna Gorkavenko
NSNadezhda Smurova
Nadezhda Smurova
RZRaisa Zugeeva
Raisa Zugeeva
LRLyubov Rychkova
Lyubov Rychkova
Background: Lactobacillus paragasseri strains are widely used as probiotics. According to modern requirements, it is necessary to characterize their morphological, cultural, physiological-biochemical, and antagonistic properties, as well as to determine their virulence, toxigenicity, toxicity, and secondary metabolite production, to study their potential and safety. The main aim of the study was to determine the probiotic potential of the L. paragasseri lg94 strain based on its biochemical features and genomic landscape. Methods: L. paragasseri lg94 was isolated from human feces. The genus and species were determined by mass spectrometry using the MALDI Biotyper. The main cultural, biochemical, and genomic characteristics of L. paragasseri lg94 were established. The biochemical profile and L-lactic acid content of the strain were determined. Additionally, the strain’s resistance to bile and low pH stress, as well as its antibiotic susceptibility, were assessed. The genomic sequence of strain lg94 was obtained using Illumina NextSeq550 sequencing. Results: In this study, the strain lg94 isolated from the feces of a healthy child was identified as L. paragasseri. After 24 h of cultivation in API 50 CH/CHL medium, strain lg94 exhibited positive results in the fermentation of 25 carbohydrates. Strain lg94 exhibited intense L-lactic acid production, reaching a concentration of 6.41 g/L in 24 h of cultivation, indicating high acid-forming capacity. The results showed that L. paragasseri lg94 demonstrated low resistance to acid stress (pH 2.0) but high resistance to 0.3% bile, with no changes in colony morphology observed. The disk diffusion assay revealed that L. paragasseri lg94 was phenotypically susceptible to several antibiotics, including ampicillin, amoxicillin, penicillin G, tetracycline, erythromycin, and chloramphenicol, with intermediate resistance to oxacillin and resistance to fosfomycin, gentamicin, and clindamycin. The whole-genome of L. paragasseri lg94 was sequenced. The absence of antibiotic resistance, pathogenicity, and virulence determinants in the genome was confirmed. Strain lg94 has genes for the production of gassericin T, enterolysin A, and helveticin J. Conclusions: The results of the studies showed that L. paragasseri lg94 has probiotic potential, and it is recommended to continue studying its antagonistic activity and secondary metabolite production.

26 December 2025 in Pathophysiology
Verified
Journal Article
Open access
PDF file
NSNatalya Semenova
Natalya Semenova
NGNadezhda Garashchenko
Nadezhda Garashchenko
ONOlga Nikitina
Olga Nikitina
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
NBNatalia Belkova
Natalia Belkova
LKLiubov Kolesnikova
Liubov Kolesnikova
Background: Menopause, a critical period during a woman’s life, is characterized by various changes, including disturbances in their oxidative balance and circadian rhythm. Currently, the gut microbiome is suggested as an important participant in these processes. Methods: This study involved 96 menopausal women. Their sleep quality was assessed using three questionnaires: the Insomnia Severity Index (ISI), the Pittsburgh Sleep Quality Index (PSQI), and the Epworth Sleepiness Scale (ESS). The GSH and GSTP1 contents in the serum were measured by means of immunoassay methods, while the composition of the gut microbiome was determined via molecular genetic methods. Results: E. coli, K. oxytoca, S. aureus, Enterobacter spp., Shigella spp., Streptococcus spp., Prevotella spp., and M. stadmanae were found to correlate with the GSH content in different sleep groups, while the presence of K. oxytoca, S. aureus, Enterococcus spp., K. pneumoniae, and M. stadmanae is also important for the GSH level in several of these groups. F. prausnitzii, S. aureus, P. micra, Acinetobacter spp., and E. rectale are associated with GSTP1 concentration in various sleep groups, while the presence of F. nucleatum and P. micra is also relevant for the GSTP1 content in some of these groups. Conclusions: Thus, in menopausal women, the composition and structure of the gut microbiota are associated with sleep disorders. GSH and GSTP1 are associated with some gut microbiome markers in menopausal women, but these relationships differ in different sleep disorders.